Belén Castillo-Cano, Marc Comas-Cufí, Elisa Martín-Merino
{"title":"在动态队列中处理疫苗类型缺失数据,以评估时变疫苗接种与自身免疫性疾病之间的联系。","authors":"Belén Castillo-Cano, Marc Comas-Cufí, Elisa Martín-Merino","doi":"10.1002/pds.70060","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The information about the type of vaccine administrated may be missing in patients' health records. We aimed to apply a simple strategy, based on several factors, to impute, when missing, the type of administrated human papillomavirus (HPV) vaccines to study its association with thyroiditis.</p><p><strong>Methods: </strong>The cohort study included Spanish health records (BIFAP) of girls. Follow-up time was divided into non-exposed, exposed, and post-exposed. The vaccine type was obtained through a single stochastic imputation based on (non)clinical factors associated with both, missing and recorded values of 1st dose, confounders and outcome. HRs were estimated after imputation. As a secondary analysis, these were compared to other strategies: using only girls with vaccine type recorded (complete cases; CC) and all girls, including those without type recorded in a missing category (MiCat).</p><p><strong>Results: </strong>A total of 808 201 observations for 388 411 girls were built. Vaccination type was carried out in 2.84% of 153 924 vaccinated girls remaining 35% for imputation. Fifteen factors associated and four confounders were identified for the imputation. HR departed by up to 10% overestimation for bi- and 10% underestimation for quadri- valent in the MiCat, whilst 24% and 3% respectively in the CC.</p><p><strong>Conclusions: </strong>In our example, multiple factors associated with HPV vaccine type missing and values were identified suggesting missing not completely at random. Thus, CC and MiCat could bias the estimates. Those factors were used for imputation, doing more plausible the missing at random assumption. This strategy was simple, efficient and can be easily applied to analyses time-varying exposure in pharmacoepidemiology.</p>","PeriodicalId":19782,"journal":{"name":"Pharmacoepidemiology and Drug Safety","volume":"33 12","pages":"e70060"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Handling With Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time-Varying Vaccination and an Autoimmune Disease.\",\"authors\":\"Belén Castillo-Cano, Marc Comas-Cufí, Elisa Martín-Merino\",\"doi\":\"10.1002/pds.70060\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The information about the type of vaccine administrated may be missing in patients' health records. We aimed to apply a simple strategy, based on several factors, to impute, when missing, the type of administrated human papillomavirus (HPV) vaccines to study its association with thyroiditis.</p><p><strong>Methods: </strong>The cohort study included Spanish health records (BIFAP) of girls. Follow-up time was divided into non-exposed, exposed, and post-exposed. The vaccine type was obtained through a single stochastic imputation based on (non)clinical factors associated with both, missing and recorded values of 1st dose, confounders and outcome. HRs were estimated after imputation. As a secondary analysis, these were compared to other strategies: using only girls with vaccine type recorded (complete cases; CC) and all girls, including those without type recorded in a missing category (MiCat).</p><p><strong>Results: </strong>A total of 808 201 observations for 388 411 girls were built. Vaccination type was carried out in 2.84% of 153 924 vaccinated girls remaining 35% for imputation. Fifteen factors associated and four confounders were identified for the imputation. HR departed by up to 10% overestimation for bi- and 10% underestimation for quadri- valent in the MiCat, whilst 24% and 3% respectively in the CC.</p><p><strong>Conclusions: </strong>In our example, multiple factors associated with HPV vaccine type missing and values were identified suggesting missing not completely at random. Thus, CC and MiCat could bias the estimates. Those factors were used for imputation, doing more plausible the missing at random assumption. This strategy was simple, efficient and can be easily applied to analyses time-varying exposure in pharmacoepidemiology.</p>\",\"PeriodicalId\":19782,\"journal\":{\"name\":\"Pharmacoepidemiology and Drug Safety\",\"volume\":\"33 12\",\"pages\":\"e70060\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pds.70060\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology and Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pds.70060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Handling With Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time-Varying Vaccination and an Autoimmune Disease.
Objective: The information about the type of vaccine administrated may be missing in patients' health records. We aimed to apply a simple strategy, based on several factors, to impute, when missing, the type of administrated human papillomavirus (HPV) vaccines to study its association with thyroiditis.
Methods: The cohort study included Spanish health records (BIFAP) of girls. Follow-up time was divided into non-exposed, exposed, and post-exposed. The vaccine type was obtained through a single stochastic imputation based on (non)clinical factors associated with both, missing and recorded values of 1st dose, confounders and outcome. HRs were estimated after imputation. As a secondary analysis, these were compared to other strategies: using only girls with vaccine type recorded (complete cases; CC) and all girls, including those without type recorded in a missing category (MiCat).
Results: A total of 808 201 observations for 388 411 girls were built. Vaccination type was carried out in 2.84% of 153 924 vaccinated girls remaining 35% for imputation. Fifteen factors associated and four confounders were identified for the imputation. HR departed by up to 10% overestimation for bi- and 10% underestimation for quadri- valent in the MiCat, whilst 24% and 3% respectively in the CC.
Conclusions: In our example, multiple factors associated with HPV vaccine type missing and values were identified suggesting missing not completely at random. Thus, CC and MiCat could bias the estimates. Those factors were used for imputation, doing more plausible the missing at random assumption. This strategy was simple, efficient and can be easily applied to analyses time-varying exposure in pharmacoepidemiology.
期刊介绍:
The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.
Particular areas of interest include:
design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;
comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;
methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;
assessments of harm versus benefit in drug therapy;
patterns of drug utilization;
relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;
evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.